Non‐Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis

Biochemical response stratifies risk of clinical events in PBC patients under OCA treatment. Whilst response rates increase over time, discontinuation rates underscore the need for newer treatment paradigms.

Authors

Institutions

Publication Details

Journal
Alimentary Pharmacology & Therapeutics
Published
2025-09-22
DOI
https://doi.org/10.1111/apt.70378
Citations
3
Primary Topic
Liver Diseases and Immunity
Type
article
Field-Weighted Citation Impact
3.97

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Non‐Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis

James Ferguson, Douglas Thorburn, Aldo J. Montaño‐Loza, Amal Almahroos et al.
3 citations
Alimentary Pharmacology & Therapeutics
Liver Diseases and Immunity
3.97
article

Non‐Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis

James Ferguson, Douglas Thorburn, Aldo J. Montaño‐Loza, Amal Almahroos, Marco Carbone, Emma Louise Culver, George F. Mells, Nadia Eden, Palak Trivedi, Pietro Invernizzi, Nadir Abbas, Sanchit Sharma, Neil Halliday, Jessica Dyson, Rachel A. Smith, David Jones, Ellina Lytvyak, Miki Scraravaglio, Diane Lloyd‐Madden
article en
3 citations

Abstract

Biochemical response stratifies risk of clinical events in PBC patients under OCA treatment. Whilst response rates increase over time, discontinuation rates underscore the need for newer treatment paradigms.

Alimentary Pharmacology & TherapeuticsVol. 63(4)
University of Alberta (CA), Royal Free London NHS Foundation Trust (GB), University of Cambridge (GB), Queen Elizabeth Hospital Birmingham (GB), Newcastle upon Tyne Hospitals NHS Foundation Trust (GB), John Radcliffe Hospital (GB), University of Alberta Hospital (CA), NIHR Birmingham Liver Biomedical Research Unit (GB), Institut de Recherche en Santé Digestive (FR), Institute of Immunology (HR), NIHR Newcastle Biomedical Research Centre (GB), ERN GUARD-Heart (NL), Immune Regulation (United Kingdom) (GB), NIHR Birmingham Biomedical Research Centre (GB), Institute of Infection and Immunity (CA), University College London (GB), University of Milano-Bicocca (IT), Newcastle University (GB)
National Institute for Health and Care Research
Openalex Percentile: Top 5%
Liver Diseases and Immunity
3.97
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.